Elecsys Anti-HBc II

FDA Premarket Approval P100032 S021

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

DeviceElecsys Anti-HBc II
Generic NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
ApplicantROCHE DIAGNOSTICS CORP.9115 Hague Rd.indianapolis, IN 46250 PMA NumberP100032 Supplement NumberS021 Date Received09/30/2021 Decision Date04/04/2022 Product Code LOM  Advisory Committee Microbiology Supplement Typenormal 180 Day Track Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No
Date Received2021-09-30
Decision Date2022-04-04
PMAP100032
SupplementS021
Product CodeLOM 
Advisory CommitteeMicrobiology
Supplement TypeNormal 180 Day Track
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination ProductNo
Applicant AddressROCHE DIAGNOSTICS CORP.
9115 Hague Rd.
indianapolis, IN 46250 PMA NumberP100032 Supplement NumberS021 Date Received09/30/2021 Decision Date04/04/2022 Product Code LOM  Advisory Committee Microbiology Supplement Typenormal 180 Day Track Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No Combination ProductNo Approval Order Statement  
Modification Of The Assay Reagents To Improve The Tolerance To Biotin Interference, Updating The Sample Stability Claims, And Revisions To The Device Labeling.

Supplemental Filings

Supplement NumberDateSupplement Type
P100032Original Filing
S021 2021-09-30 Normal 180 Day Track
S020 2018-10-26 Normal 180 Day Track No User Fee
S019 2018-10-09 30-day Notice
S018 2018-03-01 Real-time Process
S017 2017-10-11 Real-time Process
S016 2017-08-03 30-day Notice
S015 2017-05-24 30-day Notice
S014 2017-02-21 Normal 180 Day Track
S013 2016-02-16 30-day Notice
S012 2016-01-27 30-day Notice
S011 2016-01-27 135 Review Track For 30-day Notice
S010 2015-10-07 30-day Notice
S009 2013-04-09 Real-time Process
S008 2012-11-30 30-day Notice
S007 2012-09-04 Normal 180 Day Track
S006 2012-02-29 30-day Notice
S005 2012-01-31 135 Review Track For 30-day Notice
S004 2011-08-29 135 Review Track For 30-day Notice
S003 2011-08-17 Normal 180 Day Track No User Fee
S002 2011-08-17 135 Review Track For 30-day Notice
S001 2011-07-01 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.